Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus
- PMID: 16825342
- DOI: 10.1152/ajprenal.00491.2005
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus
Abstract
In the renal collecting duct, water reabsorption is regulated by the antidiuretic hormone vasopressin (AVP). Binding of this hormone to the vasopressin V2 receptor (V2R) leads to insertion of aquaporin-2 (AQP2) water channels in the apical membrane, thereby allowing water reabsorption from the pro-urine to the interstitium. The disorder nephrogenic diabetes insipidus (NDI) is characterized by the kidney's inability to concentrate pro-urine in response to AVP, which is mostly acquired due to electrolyte disturbances or lithium therapy. Alternatively, NDI is inherited in an X-linked or autosomal fashion due to mutations in the genes encoding V2R or AQP2, respectively. This review describes the current knowledge of the cell biological causes of NDI and how these defects may explain the patients' phenotypes. Also, the increased understanding of these cellular defects in NDI has opened exciting initiatives in the development of novel therapies for NDI, which are extensively discussed in this review.
Similar articles
-
Aquaporin 2 mutations in nephrogenic diabetes insipidus.Semin Nephrol. 2008 May;28(3):252-65. doi: 10.1016/j.semnephrol.2008.03.006. Semin Nephrol. 2008. PMID: 18519086 Review.
-
V2R mutations and nephrogenic diabetes insipidus.Prog Mol Biol Transl Sci. 2009;89:15-29. doi: 10.1016/S1877-1173(09)89002-9. Epub 2009 Oct 7. Prog Mol Biol Transl Sci. 2009. PMID: 20374732 Review.
-
Nephrogenic diabetes insipidus.Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006. Adv Chronic Kidney Dis. 2006. PMID: 16580609 Review.
-
Physiopathology and diagnosis of nephrogenic diabetes insipidus.Ann Endocrinol (Paris). 2012 Apr;73(2):128-9. doi: 10.1016/j.ando.2012.03.032. Epub 2012 Apr 13. Ann Endocrinol (Paris). 2012. PMID: 22503803 Review.
-
Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?Exp Physiol. 2009 Feb;94(2):186-90. doi: 10.1113/expphysiol.2008.043000. Epub 2008 Sep 12. Exp Physiol. 2009. PMID: 18790812 Review.
Cited by
-
Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.Endocr Rev. 2013 Apr;34(2):278-301. doi: 10.1210/er.2012-1044. Epub 2013 Jan 29. Endocr Rev. 2013. PMID: 23360744 Free PMC article. Review.
-
Congenital nephrogenic diabetes insipidus: the current state of affairs.Pediatr Nephrol. 2012 Dec;27(12):2183-204. doi: 10.1007/s00467-012-2118-8. Epub 2012 Mar 17. Pediatr Nephrol. 2012. PMID: 22427315 Review.
-
Glycogen synthase kinase 3α regulates urine concentrating mechanism in mice.Am J Physiol Renal Physiol. 2015 Mar 15;308(6):F650-60. doi: 10.1152/ajprenal.00516.2014. Epub 2015 Jan 21. Am J Physiol Renal Physiol. 2015. PMID: 25608967 Free PMC article.
-
Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones.Front Pharmacol. 2022 Jan 25;13:811836. doi: 10.3389/fphar.2022.811836. eCollection 2022. Front Pharmacol. 2022. PMID: 35153784 Free PMC article.
-
Vasopressin Increases Urinary Acidification via V1a Receptors in Collecting Duct Intercalated Cells.J Am Soc Nephrol. 2019 Jun;30(6):946-961. doi: 10.1681/ASN.2018080816. Epub 2019 May 16. J Am Soc Nephrol. 2019. PMID: 31097611 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous